¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acute phase substances"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • acute epidemic leukoencephalitis
    ±Þ¼º À¯Ç༺ ¹é(Áú)³ú¿°(¡­êüú¼àõÛÜòõÒàæú).
  • acute epididymitis
    ±Þ¼º ºÎ°íȯ¿°
  • acute epididymoorchitis
    ±Þ¼º °íȯºÎ°íȯ¿°
  • acute esophagitis
    ±Þ¼º ½Äµµ¿°(¡­ãÝÔ³æú).
  • acute exacerbation
    ±Þ¼º Áõ¿À(¡­ñóç÷).
  • acute exposure
    ±Þ¼ºÇÇÆø
  • acute extradural hemorrhage
    ±Þ¼º °æ¸·¿Ü ÃâÇ÷(¡­ÌãØ¯èâõóúì).
  • acute febrile neutrophilic dermatosis ; Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ.
  • acute febrile neutrophilic dermatosis = Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ
  • acute follicular tonsillitis
    ±Þ¼º ¿©Æ÷(¼º) Æíµµ¿°
  • acute fulminating meningococcemia ; Waterhouse Friderichsen syndrome
    ±Þ¼º Àü°Ý¼º ¼ö¸·±¸±Õ±ÕÇ÷Áõ.
  • acute fulminating type
    ±Þ¼º Àü°ÝÇü.
  • acute gangrenous pulpitis
    ±Þ¼º ±«Àú¼ºÄ¡¼ö¿°(ÐáàõÎÕîÅàõöÍâÐæú).
  • acute gastric dilatation
    ±Þ¼º À§È®Àå(Áõ) (¡­êÖüªíåñø).
  • acute gastritis
    ±Þ¼º À§¿°(¡­êÖæú).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • phase, death
    »ç¸ê±â
  • phase, growth
    Áõ½Ä±â
  • phase, lag
    Áõ½ÄÁغñ±â
  • phase, log
    ´ë¼öÁõ½Ä±â, Áö¼öÁõ½Ä±â
  • phase, logarithmic
    ´ë¼öÁõ½Ä±â, Áö¼öÁõ½Ä±â
  • phase, mycelial
    ±Õ»ç»ó
  • phase, stationary
    Áõ½ÄÆòÇü±â, Á¦ÀÚ¸®¼ºÀå±â
  • phase, yeast
    È¿¸ð±â
  • phase-advanced sleep
    »óÀüÁø¼ö¸é(ßÓîñòäâ²Øù)
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • phase-contrast microscopy
    À§»óÂ÷Çö¹Ì°æ
  • phase-delayed sleep
    »óÁö¿¬¼ö¸é(ßÓòÀæÅâ²Øù)
  • placental phase
    Źݱâ
  • plateau phase
    ÆíÆò±â
  • plateau phase
    °íÁ¶±â(ÍÔðÍÑ¢)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
LEP lethal effective phase; lipoprotein electrophoresis; low egg passage; lower esophagus
LLP late luteal phase; long-lasting potentiation
LPD low-protein diet; luteal phase defect
NLP no light perception; nodular liquefying panniculitis; normal light perception; normal luteal phase
PAL pathology laboratory; peptidyl-alpha-hydroxyglycine alpha-amidating lysine phase alteration plane; p...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
LPR late phase reaction
LP luteal phase
NAPL non-aqueous phase liquid
P<0.05 phase
PVP portal venous phase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute pneumonia
    ±Þ¼º Æó·Å
    ¹ÙÀÌ·¯½º, ¼¼±Õ µî¿¡ ÀÇÇØ¼­ »ý±â´Â Æó ½ÇÁúÀÇ ±Þ¼º ¿°ÁõÀÌ°í º´º¯ÀÇ Áß½ÉÀº ÆóÆ÷ »óÇÇ, ¼¼Æ÷ °­¿¡ ÀÖÀ¸¸ç, ÆóÆ÷³»¿¡ ´Ù·®ÀÇ Ä§Ãâ¹°ÀÌ Ãæ¸¸ÇØ X-¼± Çʸ§ »ó¿¡¼­´Â ±â°üÁö °­À» Á¦¿ÜÇÏ°í ±ÕµîÇÑ ±×¸²ÀÚ·Î µÚµ¤ÀδÙ. Àü¿¡´Â °¨¿° Áúȯ Áß »óÀ§¸¦ Â÷ÁöÇϰí ÀÖ¾ú´Âµ¥ Ç×»ý ¹°ÁúÀÇ µîÀåÀ¸·Î °Ý°¨Çß´Ù. ÃÖ±Ù¿¡´Â ¿ø³»°¨¿°¿¡ µû¸¥ ³­Ä¡ÀÇ ±×¶÷ À½¼º±Õ °¨¿°ÀÌ Áõ°¡ Ãß¼¼¿¡ ÀÖ´Ù.
  • acute poliomyelitis
    ±Þ¼º ȸ¹éô¼ö¿°, ±Þ¼º ¼Ò¾Æ¸¶ºñ
    »ê¹ßÀûÀ¸·Î ¹ß»ýÇÏ´Â ±Þ¼º ¹ÙÀÌ·¯½º ÁúȯÀ¸·Î ¹ß¿­, ÀεΠ¹ßÀû, µÎÅë, ±¸Åä µîÀ» Ư¡À¸·Î ÇÏ°í ¸ñ´ú¹Ì¿Í µî ÂÊ ºÎºÐÀÇ °­Á÷À» µ¿¹ÝÇÑ´Ù.
  • acute poststreptococcal glomerulonephritis
    ±Þ¼º ¿¬¼â»ó ±¸±Õ¼º »ç±¸Ã¼ ½Å¿°
    A±º ¿¬¼â»ó ±¸±Õ °¨¿°ÀÌ ¿øÀÎÀÌ µÇ¾î ¹ß»ýÇÏ´Â ±Þ¼º ½Å¿°ÀÌ´Ù. ¿¬¼â»ó ±¸±Õ¿¡ ÀÇÇÑ Æíµµ¿° µîÀÌ Ä¡À¯µÇ¾î¼­ 1-2ÁÖ ÈÄ¿¡ µ¹¿¬ ºÎÁ¾, ÇÌ´¢, °íÇ÷¾Ð µîÀ» µ¿¹ÝÇØ¼­ ¹ßº´ÇÑ´Ù. ¼Ò¾Æ¿¡ ¸¹ÀÌ ¹ßº´Çϳª ¼ºÀο¡°Ôµµ µå¹°Áö´Â ¾ÊÀ¸¸ç, ¾à 90%´Â 1-2°³¿ù ÈÄ¿¡ ¿ÏÀüÈ÷ Ä¡À¯µÈ´Ù. Ç÷û ASLO °ªÀÇ »ó½Â°ú Ç÷û º¸Ã¼°¡ÀÇ °¨¼Ò°¡ Áø´Ü¿¡ µµ¿òÀÌ µÈ´Ù. ÀÌ Áõ»óÀº ¿¬¼â»ó ±¸±ÕÀÇ Ç׿ø°ú ±× Ç×ü¿¡ ÀÇÇÑ ¸é¿ª º¹ÇÕü ½Å¿°ÀÌ´Ù. ƯÈ÷ ¼Ò¾Æ¿¡¼­´Â ±Þ¼º±â¿¡ °íÇ÷¾Ð¿¡ ÀÇÇÑ ½ÉºÎÀü, °æ·ÃÀ» ÀÏÀ¸Å°±â ½±±â ¶§¹®¿¡ ÁÖÀǸ¦ ¿äÇÑ´Ù.
  • acute pseudomembranous candidosis
    ±Þ¼º À§¸·¼º ĵµð´ÙÁõ
  • acute psychologic distress
    ±Þ¼ºÀÇ Á¤½ÅÀû °íÅë
  • acute pulpitis
    ±Þ¼º Ä¡¼ö¿°
    Ä¡¼öÀÇ ±Þ¼º ¿°ÁõÀÌ´Ù. Ä¡¾Æ¿ì½ÄÁõÀ¸·Î ÀÕµû¶ó ¹ß»ýÇÏ´Â °Í°ú ¿Ü»óÀÌ ¿øÀÎÀÎ °ÍÀ¸·Î ±¸ºÐÇÑ´Ù. ¸ðµÎ ½ÉÇÑ ÅëÁõÀÌ ÁÖµÈ Áõ»óÀÌ´Ù. ÈÄÀÚ¿¡ À־´Â ÁøÅëÁ¦ Åõ¿©·Î Áõ»óÀÌ °¡¶ó¾É´Â °ÍÀÌ ¸¹Àºµ¥, ÀüÀÚÀÇ °æ¿ì ÁøÅëÁ¦·Î È¿°ú°¡ ¾ø°í, ¹ßÄ¡ÇÏÁö ¾ÊÀ¸¸é ¾È µÈ´Ù.
  • acute pyelonephritis
    ¸¸¼º ½Å¿ì½Å¿°
    ¸¸¼ºÀÇ ¼¼´¢°ü °£ÁúÀÇ ¿°Áõ°ú ½Å Á¶Á÷ÀÇ ¹ÝÈç ¹× ½Å¹è¿Í ½Å¿ìÀÇ º´º¯À» µ¿¹ÝÇÏ´Â ÁúȯÀÌ´Ù. ¸¸¼º ½Å¿ì½Å¿°Àº ¸»±â ½Å ÁúȯÀÇ Áß¿äÇÑ ¿øÀÎÀ¸·Î ½Å ÀÌ½Ä È¯ÀÚ³ª Åõ¼® ȯÀÚÀÇ 11-20%¸¦ Â÷ÁöÇÑ´Ù. ¸¸¼º ½Å¿ì½Å¿°Àº ¸¸¼º Æó¼â¼º ½Å¿ì½Å¿°°ú ¿ª·ù¼º ½Åº´ÁõÀ¸·Î ³ª´«´Ù.
  • acute radiation sickness
    ±Þ¼º ¹æ»ç¼±Áõ
    ±Þ¼º ¹æ»ç¼± Àå¾Ö °¡¿îµ¥ Àü½Å Áõ»óÀ¸·Î¼­ ³ªÅ¸³ª´Â °ÍÀ» ¸»ÇÑ´Ù. Áï ÇÇ·Î, ½Ä¿å °¨Åð, ¿À½É, ±¸Åä µîÀÇ Áõ»óÀÌ ³ªÅ¸³­´Ù. ´ëºÎºÐ Àü½Å¿¡ ÇÇÆøÇÑ °æ¿ì¿¡ »ý±â´Âµ¥ ±¹¼Ò ÇÇÆøÀÌ¶óµµ ¾çÀÌ ¸¹À» ¶§¿¡´Â »ý±ä´Ù. ƯÈ÷ ¹æ»ç¼± Ä¡·áÀÇ °æ¿ì¿¡µµ ³ú³ª º¹ºÎ¿¡ Á¶»çÇÑ °æ¿ì¿¡ ÀÏÀ¸Å°±â ½±´Ù.
  • acute rejection vasculitis
    ±Þ¼º °ÅºÎ Ç÷°ü¿°
    ÀÌ½Ä ÈÄ ¸î °³¿ù ³»¿¡ ³ªÅ¸³ª°Å³ª ¸é¿ª¾ïÁ¦¿ä¹ýÀ» Áß´ÜÇßÀ» ¶§ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. ÀÌ·¯ÇÑ È¯ÀÚ´Â ÀÌ½Ä Àå±âÀÇ ±â´ÉÀå¾Ö°¡ ÀÌ½Ä ¼ö¼ú ÈÄ °©Àڱ⠳ªÅ¸³ª¼­ Áö¼Ó¼ºÀ» º¸ÀÌ¸ç °í´ÜÀ§ÀÇ ¸é¿ª¾ïÁ¦¿ä¹ý¿¡ ÀÇÇØ¼­µµ Àß Ä¡À¯µÇÁö ¾Ê´Â´Ù.
  • acute respiratory distress syndrome
    ±Þ¼º È£Èí°ï¶õ ÁõÈıº
    ¼ºÀΠȣÈíºÎÀü, ¼ï Æó, ¹Ì¸¸¼º ÆóÆ÷ ¼Õ»ó, ±Þ¼º ÆóÆ÷ ¼Õ»ó, ¿Ü»ó¼º ÀæÀº Æó µîÀÌ ÀÖ´Ù. ¹Ì¸¸¼ºÀ¸·Î ÆóÆ÷ ¸ð¼¼Ç÷°üÀÌ ¼Õ»óÀ» ÀÔ¾î ÃÊ·¡µÇ¸ç ÀÓ»óÀûÀ¸·Î´Â ±Þ°ÝÈ÷ »ý±ä ½ÉÇÑ È£Èí°ï¶õ, ºó¸Æ, û»öÁõ ¹× »ê¼Ò¿ä¹ý¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â µ¿¸Æ Àú»ê¼ÒÁõ µîÀ» Ư¡À¸·Î ÇÑ´Ù.
  • acute rheumatic arthritis
    ±Þ¼º ·ù¸¶Æ¼½º¼º °üÀý¿°
  • acute rheumatic polyarthritis
    ±Þ¼º ·ù¸¶Æ¼½º¼º ´Ù¹ß °üÀý¿°, ±Þ¼º ·ù¸¶Æ¼½º¼º ´Ù¹ß¼º °üÀý¿°
  • acute rhinitis
    ±Þ¼º ºñ¿°
    ÄÚ¿¡ »ý±â´Â ±Þ¼º ¿°Áõ.
  • acute serum sickness
    ±Þ¼º Ç÷ûº´
    Àü½Å¼º ¸é¿ªº¹ÇÕü ÁúȯÀÇ ÀüÇüÀûÀÎ ¿¹ÀÌ´Ù. Çѵ¿¾È Çǵ¿¼º ¸é¿ªÀ» À§ÇØ »ç¿ëµÈ ´Ù·®ÀÇ ÀÌÁ¾ Ç÷ûÀÇ Åõ¿©¿¡ µû¸¥ ÈÄÀ¯ÁõÀÌ´Ù.
  • acute situational stress reaction
    ±Þ¼º »óȲ¼º ½ºÆ®·¹½º ¹ÝÀÀ
    ±ØµµÀÇ È¯°æÀû ½ºÆ®·¹½º¿¡ ´ëÇÑ ÀϽÃÀûÀÎ ¹ÝÀÀÀ¸·Î ±âÃÊÀûÀÎ Á¤½Å Àå¾Ö°¡ ¾ø´Â °³Àο¡°Ô ³ªÅ¸³­´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
acute inclusion body encephalitis The most common acute encephalitis, caused by HSV-1; affects persons of any age; preferentially involves the inferomedial portions of the temporal lobe and the orbital portions of the frontal lobes; pathologically, severe haemorrhagic necrosis is present along with, in the acute stages, intranuclear eosinophilic inclusion bodies in the neurons and glial cells.
Synonym: acute inclusion body encephalitis, herpes encephalitis.
(05 Mar 2000)
acute infectious nonbacterial gastroenteritis An epidemic, highly communicable but rather mild disease of sudden onset, caused by the epidemic gastroenteritis virus (especially Norwalk agent), with an incubation period of 16 to 48 hours and a duration of 1 to 2 days, which affects all age groups; infection is associated with some fever, abdominal cramps, nausea, vomiting, diarrhoea, and headache, one or another of which may be predominant.
Synonym: acute infectious nonbacterial gastroenteritis.
(05 Mar 2000)
acute inflammation Any inflammation that has a fairly rapid onset, quickly becomes severe, usually manifested for only a few days, but may persist for several days or even a few weeks.
Synonym: active inflammation.
(05 Mar 2000)
acute inflammatory polyneuropathy <neurology, syndrome> Acute infective polyneuritis that results in a form of peripheral neuropathy with temporary loss of movement and sensation due to inflammation of multiple nerves and loss of myelin.
The exact cause is unknown but has been associated with an abnormal immune response to viral infection, particularly cytomegalovirus infection, in which there is cell-mediated immunity to a component of myelin. The disease may be autoimmune in origin and complete recovery can take up to six months.
Synonym: Guillain-Barre syndrome
(12 Jul 2000)
acute intermittent porphyria <gastroenterology, haematology> A group of rare inherited metabolic disorders that result from a disturbance in porphyrin metabolism, causing increased formation and excretion of porphyrin or its precursors.
It is caused by hepatic overproduction of d-aminolevulinic acid, which has greatly increased urinary excretion and of porphobilinogen, and some increase of uroporphyrin, due to a deficiency of porphobilinogen deaminase.
Clinical features: intermittent acute attacks of hypertension, abdominal colic, psychosis, and polyneuropathy, but with no photosensitivity.
It is exacerbated by the ingestion of certain drugs such as; barbiturates).
Inheritance: autosomal dominant.
(20 Sep 2002)
acute interstitial nephritis <nephrology> A relatively uncommon condition which is characterised by inflammation of the renal tubules, glomeruli and surrounding tissue. Interstitial nephritis is usually be temporary and often associated with the use of a particular medication. Chronic and progressive forms do exist.
Drugs that have been associated with interstitial nephritis include penicillins, ampicillin, sulpha drugs, non-steroidal anti-inflammatory agents, furosemide and thiazide diuretics. May result in mild kidney dysfunction or acute renal failure. Treatment may be with corticosteroids.
Incidence: 1 in 25,000.
(29 Dec 1997)
acute interstitial pneumonia A severe and usually fatal form of pneumonia occurring primarily in infants usually considered a form of hypersensitivity pneumonitis.
(05 Mar 2000)
acute interstitial pneumonitis Usually considered a form of hypersensitivity pneumonitis.
(05 Mar 2000)
acute kidney failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
acute kidney transplant rejection <radiology> Findings on ultrasound: globular enlargment of the kidney, swelling and hypoechogenicity of the medullary pyramids, indistinct cortico-medullary junction, foci in the renal cortex
(12 Dec 1998)
acute leukaemia <haematology> A rapidly progressive cancer of the blood of sudden onset and characterised by the uncontrolled proliferation of immature blood cells which take over the bone marrow and spill into the blood stream. If left untreated is fatal within a few weeks or months.
See: acute lymphoblastic leukaemia, acute myeloid leukaemia.
Origin: Gr. Haima = blood
(11 Nov 1997)
acute lobar nephrosis A severe but localised bacterial infection of the renal parenchyma that may produce a mass effect simulating a renal abscess.
(05 Mar 2000)
acute lower GI haemorrhage <gastroenterology> Typical presentation: Sudden onset of brisk rectal bleeding without blood in gastric aspirate Diagnostic considerations: diverticulosis, angiodysplasia, ischemic colitis, inflammatory bowel disease (rarely), polyps are usually present, carcinoma causing a chronic bleed, haemorrhoids.
(12 Dec 1998)
acute lymphoblastic leukaemia <haematology> A rapidly progressing cancer of the blood affecting the type of white blood cell known as lymphocytes. Approximately 650 new cases are diagnosed every year in the UK and it is the most common form of childhood leukaemia.
Acronym: ALL
Origin: Gr. Haima = blood
(11 Nov 1997)
acute lymphocytic leukaemia <radiology> 95% of cases of leukaemia in children, bone changes in 50-70% of kids (vs. 10% in adults); seen as early as 1 month after onset of symptoms, wrists and knees most commonly affected, bony defects: metaphyseal radiolucent bands! (similar findings in scurvy, JRA, syphilis), osteolytic lesions, periosteal reaction, osteosclerosis
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á